Lv71
4410 积分 2020-07-19 加入
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
1小时前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
1小时前
已完结
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials
1小时前
已完结
Hemophagocytic Lymphohistiocytosis in Adults
4天前
待确认
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
26天前
已完结
Human missense variants in F3 impair the initiation of blood coagulation
1个月前
已关闭
Thrombotic Microangiopathies
1个月前
已完结
Molecular Basis of Thrombotic Microangiopathy
1个月前
已完结
A missense mutation in lectin domain of thrombomodulin causing functional deficiency
2个月前
已完结
Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed/Refractory NK/T-Cell Lymphoma
3个月前
已完结
皖公网安备34019202002308
